Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
2022 · Cancer Cell · 336 citations
https://doi.org/10.1016/j.ccell.2022.07.002
K
Kara Johnson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
3.1K
Citations
19
h-index
20
i10-index
Kara Johnson is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: T-cell and Retrovirus Studies & Chronic Myeloid Leukemia Treatments & CAR-T cell therapy research. The author has an h-index of 19, co-authored 88 publications.
ORCID: 0000-0002-0993-4470Papers by this author
worksLocal Food System Approaches to Address Food and Nutrition Security among Low-Income Populations: A Systematic Review
2024 · Advances in Nutrition · 38 citations
https://doi.org/10.1016/j.advnut.2023.100156
Supplementary Figure S5 from Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031756
Supplementary Figure S3 from Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031762
Supplementary Figure S3 from Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031762.v1
Supplementary Figure S2 from Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031765.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat